1. Home
  2. OZ vs RNAC Comparison

OZ vs RNAC Comparison

Compare OZ & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belpointe PREP LLC Units

OZ

Belpointe PREP LLC Units

HOLD

Current Price

$50.18

Market Cap

196.2M

Sector

N/A

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.66

Market Cap

168.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OZ
RNAC
Founded
2020
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.2M
168.3M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
OZ
RNAC
Price
$50.18
$8.66
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$34.00
AVG Volume (30 Days)
9.2K
184.8K
Earning Date
05-19-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,187,000.00
$2,797,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
243.44
N/A
52 Week Low
$48.50
$5.60
52 Week High
$69.00
$14.56

Technical Indicators

Market Signals
Indicator
OZ
RNAC
Relative Strength Index (RSI) 43.59 68.98
Support Level $50.00 $5.89
Resistance Level $57.63 $9.25
Average True Range (ATR) 0.71 0.56
MACD 0.01 0.24
Stochastic Oscillator 34.16 83.41

Price Performance

Historical Comparison
OZ
RNAC

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset. The majority of the revenue is earn from mixed-use segment.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: